Finke Daniel P
Known title: EVP/Pres, Health Care BenefitsCIK: 0001844305
Associated companies
Transaction History
| CVS | ▼ Sell | Tax Withholding | 3,856 | $287K | 4/1/2023 | View on chart |
| CVS | ▲ Buy | Option Exercise | 9,546 | $500K | 8/3/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 9,546 | $955K | 8/3/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 5,941 | $594K | 4/5/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 16,161 | $1.6M | 4/4/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 27,166 | $2.7M | 4/4/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 27,166 | $1.6M | 4/4/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 16,161 | $876K | 4/4/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 12,032 | $1.2M | 4/4/2022 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 13,532 | $1.4M | 4/1/2022 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 3,856 | $390K | 4/1/2022 | View on chart |
| CVS | ▲ Buy | Grant | 34,387 | $0 | 2/21/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status
CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.